Hangeshashinto, a traditional Japanese kampo medicine composed of seven crude herbs, significantly reduces the severity and duration of oral mucositis in cancer patients undergoing chemotherapy, according to a systematic review and meta-analysis published in Supportive Care in Cancer. The condition, characterized by painful ulcerations of the mucous membranes in the mouth, remains a dose-limiting toxicity for individuals receiving systemic cancer treatments.
Clinical Efficacy and Findings
The systematic review synthesized data from multiple randomized controlled trials to evaluate the prophylactic and therapeutic utility of Hangeshashinto (TJ-14) against chemotherapy-induced oral mucositis. According to the pooled data analyzed in the study, patients who gargled with the botanical extract experienced a shortened duration of severe ulcerative lesions compared to control groups receiving standard care or placebo rinses. The multi-herbal formulation contains processed pinellia tuber, scutellaria root, glycyrrhiza, jujube, ginseng, coptis rhizome, and dried ginger. Pharmacological analyses cited within the review indicate that constituents like baicalin and berberine exert anti-inflammatory and antimicrobial effects, which help suppress local tissue damage and secondary infections in the oral cavity.
Mechanism of Action and Safety Profile
Oral mucositis develops when cytotoxic chemotherapy agents damage the rapidly dividing basal epithelial cells of the oral mucosa, triggering an inflammatory cascade. According to clinical evaluations referenced in the research, Hangeshashinto mitigates this damage by inhibiting inflammatory cytokine production and downregulating nuclear factor-kappa B (NF-$\kappa$B) pathways in oral keratinocytes. Researchers noted that the intervention demonstrated a favorable safety profile with minimal adverse events reported across the evaluated cohorts, making it a viable adjunct therapy alongside conventional oncology protocols. Gastrointestinal side effects were rare, and patients tolerated the liquid gargle preparation well throughout their treatment cycles.
Implications for Oncology Care
Severe oral mucositis frequently forces oncologists to delay chemotherapy schedules or reduce drug dosages, potentially compromising overall cancer treatment efficacy. By incorporating evidence-based supportive interventions like Hangeshashinto, clinical teams can better manage mucosal toxicity and maintain patient nutritional intake and quality of life. The findings provide a robust framework for integrating traditional Japanese kampo medicine into modern supportive oncology care, though clinicians emphasize the need for continued large-scale, multi-center trials to standardize dosing regimens across diverse chemotherapy regimens.
Keep reading